Member Info for KilkennyTed

Co-dependants

The Taiwanese divestment has a few conditions attached. So the amounts mentioned aren't guaranteed and certainly not guaranteed to be paid on time.

$4m (approx £3.2m).

Key terms of the Divestment include:

· Upfront payment: US$1m payable on the Closing Date; plus

· Loan agreement: US$1m payable as a lump sum or via ad hoc instalments within two years of the Closing Date (carrying interest at 7 per cent. above the Bank of England base rate) ("Loan Agreement"); plus

· Earn-out consideration: up to US$2m potential earnout subject to the achievement of certain profit related milestones, over the next two calendar years post completion.

· The Loan Agreement is secured against the shares of the subsidiary being sold such that failure to pay will result in ownership returning to Yourgene with no obligation to return previously received funds.

Looks like Yourgene will run out of cash end of September, October at the latest.

From todays rns:

In January 2023, Yourgene completed a capital raising generating net cash proceeds of approximately £6.8 million. As at 31 March 2023, Yourgene had an unaudited cash balance of £2.8 million.

As at 26 June 2023, Yourgene's unaudited cash balance was £1.88 million, with an unaudited bank debt of £2.5 million. As at 24 July 2023, Yourgene's unaudited cash balance was £1.3 million, with an unaudited bank debt of £2.3 million. Yourgene continues to manage its working capital prudently.

Davand. Any idea of the values involved? How much revenue has this deal brought in over the past 5 years?

Nice to see the volume is good again today Over 1m traded 8n France in first hour. 0.83 at present.

Uk 429k traded 0.72

Nice to see a bit of volume today. Kept going aswell, approx 296k shares traded in last 30 mins. Finishing near the day high. Hopefully it'll push on again tomorrow. But this is AIM so no guarantee's.

How's the party going??

Keeppluggingaway

Posted in: NCYT

Posts: 67

Price: 38.00

No Opinion

10p party book now..30 Jun 2023 12:15

Tickets are selling fast....10p club.

France

0.6360

+0.0960

(+17.78%)

7 new multiplex products (6 on the list plus GI product they tweeted about on Monday).

Plus from recent past.

2 Co-Prep instruments launched (apparently)

2 LFT readers launched (apparently)

Yet not one rns. You certainly can't call the BoD a bunch of rampers. Many other things yes.

Https://www.chayon.co.kr/email/2023/template/genesig.pdf

South Korean agent showing the vast range of products in the Genesig portfolio. Try & find the covid products.

POINT OF CARE TESTING

National Strategic Guidance for at Point of Need Testing

Technology

Lessons learned from the pandemic highlight the need for a clear use case for the type of

test and technology, the performance of the technology and the applicability of the test type

in the clinical setting being proposed. Further work is needed to define acceptable target

technical performance (TTP) characteristics for each setting that POCT is to be used to

support the selection and deployment of all equipment at the point of need.

It is acceptable for the performance of testing technology to vary dependent upon the

setting and the clinical question or purpose it is being used.

https://www.ibms.org/resources/documents/point-of-care-testing-national-strategic-guidance-for-at-point/#:~:text=This%20strategy%20sets%20out%20a,the%20centre%20of%20their%20care.

All staff aren't safe. And that is both Yourgene and Novacyt present employees. Any duplications will be cut. It's the only way this will work.

It's no golden goose Novacyt are looking to buy. No matter what potential it has it'll need a lot of hard work to turn it into a profit making business.

Who's that then? Do you know? I'm genuinely interested.

"strategic partner"

Who's that?

Then you buy shares in NCYT with the cash.

Davand what % of shares issued in the last placing make up the company now? It was over 70% wasn't it. They are all in profit. It's the real LTH's who are taking the pain, but they are in the minority now. Obviously some will have taken up options at the heavily discounted rate to get their average down.

Ygen were trading for 0.19/0.2p last week & not being snapped up, so I feel there aren't many better offers coming. I may be wrong but don't see many shelling out £25 million+ for the company.

But the shareholders have the right to vote against the deal & see where that takes them.

Good luck

Novacyts cash that is.

Davand "This really will be a bargain at twice the price. Cut the fat out at Ygen, (and there is plenty) and you're straight into profit. They have really good products and tech. You will probably hear more on Ranger, which could be a game changer and gaining traction every week."

You should invest in Novacyt now if the tech & products are that good. After all your seed money has more than doubled since Friday & Novacyt sp has only gone up just over 20%. Win Win. If you think about it they are buying Yourgene for cash which at the moment is valued at a third of it's value.

I'm sure Ygen holders aren't happy as they probably think it's worth more. However without a takeover they would probably have had to do another fund raise in the near future. Their cash wasn't going to last forever and must have realised that it wasn't going to be cheap or easy to keep raising funds.

Https://www.londonstockexchange.com/news-article/NCYT/recommended-cash-offer-for-yourgene-health-plc/16023608